Growth Metrics

Insulet (PODD) EBIT Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -3.76%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 8.39%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.70%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 25.88%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 7.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 34.83%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 75.54%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.70%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -24.91%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 63.96%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 63.96%
Dec 31, 2025 83.96%
Sep 30, 2025 243.66%
Jun 30, 2025 86.97%
Mar 31, 2025 32.82%
Dec 31, 2024 30.04%
Sep 30, 2024 37.76%
Jun 30, 2024 27.49%
Mar 31, 2024 51.70%
Dec 31, 2023 155.04%
Sep 30, 2023 32.05%
Jun 30, 2023 4.19%
Mar 31, 2023 54.58%
Dec 31, 2022 9.09%
Sep 30, 2022 -44.54%
Jun 30, 2022 -76.66%
Mar 31, 2022 73.16%
Dec 31, 2021 45.21%
Sep 30, 2021 69.95%
Jun 30, 2021 82.53%
Dec 31, 2020 -111.83%
Sep 30, 2020 126.54%
Jun 30, 2020 116.80%
Mar 31, 2020 50.56%
Dec 31, 2019 85.44%
Sep 30, 2019 91.57%
Jun 30, 2019 99.17%
Mar 31, 2019 43.39%
Dec 31, 2018 48.68%
Sep 30, 2018 35.07%
Jun 30, 2018 32.15%
Dec 31, 2017 -38.51%
Sep 30, 2017 39.45%
Jun 30, 2017 14.00%
Mar 31, 2017 -41.19%
Dec 31, 2016 -180.51%
Sep 30, 2016 28.86%
Jun 30, 2016 39.52%
Mar 31, 2016 -7.45%
Dec 31, 2015 -27.51%
Sep 30, 2015 -20.43%
Jun 30, 2015 -10.15%
Mar 31, 2015 12.63%
Dec 31, 2014 28.28%
Sep 30, 2014 33.47%
Jun 30, 2014 29.26%
Mar 31, 2014 36.23%
Dec 31, 2013 26.44%
Sep 30, 2013 -27.88%
Jun 30, 2013 16.22%